Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 7/20 | 0.75 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7614942 | 0.95 | NLRP3 (0.69) | NLRP3CA12CA1CA2CA9 | |
| SCHEMBL7616971 | 0.91 | NLRP3 (0.66) | NLRP3CA12CA1CA2CA9 | |
| SCHEMBL7611930 | 0.91 | NLRP3 (0.74) | NLRP3CA12CA1CA2CA9 | |
| SCHEMBL7142667 | 0.90 | NLRP3 (0.74) | NLRP3CA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL7623266 | 0.90 | NLRP3 (0.65) | NLRP3CA12CA1CA2CA9 | |
| SCHEMBL7143556 | 0.88 | NLRP3 (0.77) | NLRP3 | |
| SCHEMBL7622583 | 0.88 | NLRP3 (0.62) | NLRP3 | |
| SCHEMBL7650620 | 0.88 | NLRP3 (0.62) | NLRP3CA12CA1CA2CA9 | |
| SCHEMBL7611971 | 0.87 | NLRP3 (0.61) | NLRP3CA12CA1CA2CA9 | |
| SCHEMBL7611975 | 0.87 | NLRP3 (0.61) | NLRP3CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0964849-B1 | SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY | PFIZER (US) | 2003-06-04 | — | — | EP | disclosed |
| EP-1270565-A1 | 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives | PFIZER INC. (US) | 2003-01-02 | — | — | EP | disclosed |
| EP-1270554-A1 | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity | PFIZER INC. (US) | 2003-01-02 | — | — | EP | disclosed |
| US-6433009-B1 | TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS | PFIZER INC | 2002-08-13 | — | — | US | disclosed |
| US-6166064-A | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity | PFIZER INC (US) | 2000-12-26 | — | — | US | disclosed |